INTRODUCTION
A number of workers have described children with persistent lactic acidosis and diffuse neurologic disease including mental retardation (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . Defects in gluconeogenetic enzymes have been demonstrated in several of these patients (7, 9, 11, 14) . We have found a defect in oxidative metabolism in intact and disrupted fibroblasts cultured from the skin of a similar patient (16) and report the details of our studies below.
METHODS
Case report. The patient, a severely retarded 3 yr old girl, was born of a consanguineous marriage in an inbred Preliminary results were presented at the National Meeting of the American Federation for Clinical Research in 1970 (16) .
Received for publication 15 November 1971 and in revised form 30 January 1972. population ( Fig. 1) . Her only sibling, a sister, died in infancy. The mother experienced several episodes of weakness and sweating during the first trimester, and the level of glucose in her blood on one such occasion was recorded as 50 mg/100 ml. Fetal movements were decreased during the third trimester. Birth weight was 2.6 kg, and feeding was poor despite close parental attention. When the child was 7 months old, it was recognized that she was not developing motor skills normally but at this age deficits appeared mild. Doctors Martine Yarbro and Jaqueline Noonan first made the diagnosis of lactic acidosis at the University of Kentucky Medical Center when the child was 18 months old. Extensive studies of this patient at several medical centers have documented increasingly severe neurologic disease and are to be the subject of a separate clinical report.
On admission to the NIH, the patient had severe diffuse neurologic disease. Height and weight were normal. There were bilateral epicanthal folds, a slightly high-arched palate, and mild pectus excavatus. The head circumference (45 cm) was in the microcephalic range. Marked strabismus and severe optic atrophy were present; the patient was probably blind. Muscular hypotonia accompanied hyperactive reflexes and scissoring. Her movements were poorly coordinated, but could not be classified into a known category of movement disorder. The eye movements seemed nystagmoid to some observers. Vocabulary was about 20 words. The child was not toilet trained. She appeared grossly mentally retarded and irritable and formal psychologic testing was not attempted. Sensation appeared intact to pinprick; sweating was normal.
The patient was maintained on a high-protein diet during the completion of the laboratory studies described below. Clinical and clinical laboratory studies were limited, since informed consent for a number of procedures including dietary variation and repeated sampling of physiological fluids was not obtained. Since discharge, further deterioration of the child's condition has reportedly occurred.
Clinical laboratory studies. Lactic and pyruvic acid levels in blood were persistently elevated (Fig. 2) , despite therapy with thiamine hydrochloride (up to 600 mg orally and 200 mg parenterally, daily) or with nicotinamide (1.0 g/day orally). Citric acid levels (17) in the patient's blood = died in early childhood 4 FIGURE 1 Family tree of patient E. G. The parents of the patient are second cousins once removed. The precise cause of death of the patient's sister is unclear.
(0.14-0.21 mmoles/liter) were above the normal range (0.07-0.12 mmoles/liter). Uric acid in blood (7.6-9.8 mg/ 100 ml) was also elevated.
Serum CO2 concentration remained below 20 mEq/liter, despite therapy with 4.4 g/day of oral sodium bicarbonate. Values as low as 6 have been recorded. Serum sodium (137-141 mEq/liter), potassium (4.14.9 mEq/liter) and chloride (104-106 mEq/liter) appeared normal. Creatine phosphokinase in the serum (127 U) was slightly elevated (normal 6-50 U), as was serum aldolase (11 U; normal 3-8 U). Activities of glutamic-oxaloacetic transaminase and lactic dehydrogenase in her serum were normal.
Amino acid analysis of a single sample of urine by column chromatography demonstrated slightly increased excretion of alanine (566 vs. normal 12-500 ,umoles/24 hr). Urinary ketones appeared elevated, by the nitroprusside test. Urine contained uric acid crystals; urate excretion was 8-20 mg/(kg body weight X day). Urine pH was 5.0. Urinalysis was otherwise unremarkable.
Electroencephalography demonstrated a nonlateralized mixture of slow waves abnormal even for this age.
Normal results were obtained on hematologic examination, and on measurements of blood levels of glucose, urea, creatinine, calcium, phosphorus, bilirubin, alkaline phosphatase, total protein, cholesterol, and triglycerides. Electrophoresis of serum proteins and plasma lipoproteins gave normal patterns. Roentgenographic examinations showed a normal bone age and mild demineralization. Fibroblast incubations. Skin fibroblasts were prepared and incubated with radioactive pyruvate, palmitate, and glutamate as described previously (21) . For incubations with citric or isocitric acids, cells were treated with 0.1% trypsin for 40 min and then incubated in half isotonic buffer. Preliminary experiments indicated that oxidation of these substrates by fibroblasts was very slow unless cells were treated with detergent or hypotonic media, presumably because of slow passage of the tricarboxylic acids across the undamaged cell membrane. Control fibroblasts were from adults and children with other neurological diseases and from apparently normal foreskins.
Enzyme assays. Fibroblasts were disrupted by sonication 
RESULTS
Studies of intact fibroblasts. For all incubations, conditions were adjusted so that the production of "CO2 was proportional to the number of cells added and to the length of the incubation.' Fibroblasts from the patient oxidized pyruvic acid-[1-"C], palmitic acid-[1-"C], and citric acid-[1,5-4C] to "4CO2 to less than one-third the extent of cells from controls (Fig. 3) (Table  II) while the activity of citrate synthase in her cells was about three-fourths of that of the lowest of four controls (22) . The activity of the pyruvate dehydrogenase complex, however, was significantly lower in the patient's sonicated fibroblasts than in preparations from control cells (Table III) . The defect was as marked as that in pyruvate oxidation in her intact cells. Activity in sonicated fibroblasts from the mother was at the lower limit of the range for controls; cells from the father were not available for study. Mixing experiments did not demonstrate the presence of a soluble inhibitor of the pyruvate dehydrogenase complex in the patient's cells (Table IV) 0.059±0.014 (14) The activity of the pyruvate dehydrogenase complex was assayed in sonicated fibroblasts as described in detail in the text. Values represent means, ±SEM. The figures in parentheses represent the number of cultures examined for each individual (patient or control), or, for the total control group, the number of individuals studied. The accumulation of excess pyruvate and citrate in her blood suggested that metabolism of these compounds was defective in tissues of the intact patient. The lactic acidosis was consistent with excess glycolysis due to inadequate production of ATP by oxidative metabolism (31) .
The activity of the pyruvate dehydrogenase complex was low in cell-free preparations of the patient's fibroblasts, but we are unable to explain the low oxidation of palmitate and citrate by the patient's intact cells on the basis of that defect alone. Complex interactions do occur between the oxidation of pyruvate 'and of citrate (32) (33) (34) (35) (36) . Furthermore, the defect in this patient appears to affect one of the two latter enzymes of the pyruvate dehydrogenase complex, the last enzyme of which may be identical with the last enzyme of the a-ketoglutarate dehydrogenase complex (37, 38) . Normal (39) . More detailed studies of the human pyruvate and a-ketoglutarate dehydrogenase complexes and of carbohydrate metabolism in cultured human fibroblasts may clarify some of these problems.
The mechanism of inheritance of this defect has not been precisely defined, but the consanguinity and the low activity of pyruvate dehydrogenase in the mother's sonicated cells suggest recessive inheritance.
This patient differs both biochemically and clinically from the three children we have described with defects in the first enzyme of the pyruvate dehydrogenase complex (21, 40) . Intact fibroblasts from the patient described in this report oxidized palmitate and citrate at low rates, while with ferricyanide as electron acceptor her sonicated fibroblasts oxidized pyruvate at rates similar to controls. Intact fibroblasts from the other three patients oxidized palmitate and citrate normally, but their sonicated cells were defective in the ferricyanide-linked oxidation of pyruvate. The patient described here had severe, generalized neurologic disease. The only prominent and consistent finding in the other three was intermittent ataxia (21, 40) .
Profound neurologic disease is not surprising in a patient with a major oxidative defect. Even brief interference with oxidative metabolism by anoxia or poisons can lead to brain damage. The major normal substrate for oxidation in the nervous system is glucose (41) . Different enzymatic defects in glucose oxidation or in the supply of glucose by gluconeogenesis might be expected to lead to clinical disorders which differed in detail but which led to patients having the combination of neurologic disease and lactic acidosis. Defects in gluconeogenesis have been described in several such patients (7, 9, 11, 13, 14) , including two (11, 14) with defective hexosediphosphatase (D-Fructose-1,6-diphosphate-1-phosphohydrolase, E.C. 3.1.3.11) and two others (7, 9) with defects in pyruvate carboxylase (Pyruvate: carbon-dioxide ligase (ADP), E.C. 6.4.1.1.). Several workers have postulated defects in oxidative metabolism in other such patients, on the basis of accumulation of a-ketoglutaric acid (2, 5, 6, 10) , accumulation of glyoxylic acid (5) , increased production of lactic acid by exercising muscle (3) and by red blood cells (4), or response to therapy with lipoic acid (5, 10 (42) . The existence of mutations which cause defects of each of these three types would not be surprising.
